NFKB1 and membranous glomerulonephritis: Isoliquiritin can protect the kidney of membranous glomerulonephritis model rats through antioxidant and anti-inflammatory effects, and these effects were found to be related to the activation of Nrf2 and the down-regulation of NF-κB pathway (Liu et al., 2019).